Senior insider sale
CMO at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$127.2K
2.92K shares
What this filing means
DONOVAN JOANNE M. plans to sell 2.92K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $127.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001950047-26-008084
Officer· CMO
Since Apr 2021
2.92K
Shares to sell
$127.2K
Approx. market value
2.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/12/2025
2.92KTotal acquired2.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2025 | Restricted Stock Units N/A | 2.92K | — |
| Total | 2.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.92K
Market value
$127.2K
8/13/2026
Total
Units
2.92K
Value
$127.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 2.92K | $127.2K | NASDAQ | Planned |
| Total | 2.92K | $127.2K | ||